Adverse events associated with treatment · skin changes caused by nerve damage in leprosy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Abdominal pain · People with primary burning mouth syndrome (BMS), that is, oral mucosal pain with no dental or medical cause for such symptoms
It is very uncertain whether antidepressants (trazodone 200 mg/day) changes adverse effects: abdominal pains compared with placebo (very low certainty).
1 finding from 1 review
Treatment‐related adverse effects · adults and children with sickle cell disease experiencing neuropathic pain
It is very uncertain whether summary of findings ‐ Pharmacological intervention (pregabalin) changes treatment‐related adverse effects compared with placebo (very low certainty).
1 finding from 1 review
Adverse effects of pain treatment · People undergoing orthodontic treatment (any age; 9 to 34 years in included studies)
The review found no eligible studies for this question.
1 finding from 1 review
Adverse effects of pain treatment · Adolescents and adults undergoing orthodontic treatment
The review found no eligible studies for this question.
1 finding from 1 review
Adverse effects of pain treatment · Adults undergoing orthodontic treatment
The review found no eligible studies for this question.
1 finding from 1 review
Adverse effects of pain treatment · Adolescents/teenagers undergoing orthodontic treatment
The review found no eligible studies for this question.
1 finding from 1 review
Adverse effects of pain treatment · Adults undergoing orthodontic treatment
The review found no eligible studies for this question.
1 finding from 1 review
Adverse effects of pain treatment · Adolescents and adults undergoing orthodontic treatment
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
Adverse effects of glycopyrrolate
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Withdrawals due to adverse events · people with inflammatory bowel disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse event nausea and vomiting (0 to 24 hours) · people with traumatic hyphema
Systemic aminocaproic acid probably leads to higher adverse effects: nausea or vomiting compared with placebo (moderate certainty).
1 finding from 1 review
Adverse effects UAE vs systemic MTX · women with CSP
UAE/UACE showed no clear difference in adverse effects UAE vs systemic MTX compared with systemic MTX (low certainty).
1 finding from 1 review
Adverse effects: euphoric behaviour · People with primary burning mouth syndrome (BMS), that is, oral mucosal pain with no dental or medical cause for such symptoms
It is very uncertain whether benzodiazepines (topical clonazepam) changes adverse effects: euphoric behaviour compared with placebo (very low certainty).
1 finding from 1 review
Number of women with adverse effects · postpartum breastfeeding women
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of women with adverse effects · postpartum breastfeeding women
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects on babies: diarrhoea · women in the postpartum period
It is very uncertain whether laxative changes adverse effects on babies: diarrhoea compared with placebo (very low certainty).
1 finding from 1 review
Adverse effects Skin/local reactions · patients with Old World cutaneous leishmaniasis
It is very uncertain whether paromomycin ointment changes adverse effects Skin/local reactions compared with vehicle (very low certainty).
1 finding from 1 review
Frequency of serious adverse effects · participants with hidradenitis suppurativa
Adalimumab weekly showed no clear difference in frequency of serious adverse effects compared with placebo (moderate certainty).
1 finding from 1 review
Frequency of serious adverse effects · participants with hidradenitis suppurativa
Adalimumab every other week showed no clear difference in frequency of serious adverse effects compared with placebo (high certainty).
1 finding from 1 review